1312161-60-6 Usage
Description
(R)-3-N-Cbz-aminomethylmorpholine is a chiral morpholine derivative chemical compound, characterized by its (R) enantiomer being the active form. It is recognized for its unique chemical and biological properties, stemming from the presence of the morpholine ring structure and the Cbz (carboxybenzyl) protecting group on the amino group. (R)-3-N-Cbz-aminomethylmorpholine is a versatile intermediate in the synthesis of various biologically active molecules, making it a valuable asset in the fields of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
(R)-3-N-Cbz-aminomethylmorpholine is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and properties allow for the creation of a wide range of biologically active molecules, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
(R)-3-N-Cbz-aminomethylmorpholine is also utilized as a key intermediate in the production of agrochemicals. Its versatility in organic synthesis enables the development of novel compounds with potential applications in agriculture, such as pesticides, herbicides, and other crop protection agents.
Used in Drug Discovery and Development:
(R)-3-N-Cbz-aminomethylmorpholine serves as a valuable tool in drug discovery and development due to its unique chemical and biological properties. Its role as a versatile intermediate allows researchers to explore new avenues in the creation of innovative and effective pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 1312161-60-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,1,6 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1312161-60:
(9*1)+(8*3)+(7*1)+(6*2)+(5*1)+(4*6)+(3*1)+(2*6)+(1*0)=96
96 % 10 = 6
So 1312161-60-6 is a valid CAS Registry Number.
1312161-60-6Relevant articles and documents
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS
-
Page/Page column 109, (2009/06/27)
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischaemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes mellitus, neurodegenerative diseases, retroviral infections, retinaldamage, skin senescence and UV-induced skin damage, and as chemo-or radiosensitizers for cancer treatment.
